logo

For the Inventor, By the Inventor

Dublin, Ireland

Cosmo Technologies Limited


USPTO Granted Patents = 50

% Expired Patents = 30.0



Trademarks = 14

Forward Citations = 318

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Roberto Villa (32 out of 33 patents)

silverMedal Mauro Ajani (31 out of 44 patents)

bronzeMedal Massimo Pedrani (22 out of 23 patents)

4.  Lorenzo Fossati (22 out of 23 patents)

5.  Luigi Moro (17 out of 32 patents)

6.  Luigi Maria Longo (12 out of 16 patents)

7.  Alessandro Repici (12 out of 12 patents)

8.  Enrico Frimonti (9 out of 9 patents)

9.  Giuseppe Celasco (8 out of 8 patents)

10.  Mara Gerloni (6 out of 7 patents)

11.  Roberta Bozzella (4 out of 4 patents)

12.  Mauro Ajani Fossati (1 out of 1 patent)

13.  Franca Ferrari (1 out of 2 patents)

14.  Giuseppina Sandri (1 out of 1 patent)

15.  Silvia Rossi (1 out of 1 patent)


Core Competencies:
Oral Rifamycin
Liquid Delivery
Cortexolone
Tumor Treatment
Emulsions
Microemulsions
Controlled Release
Taste Masking
Diagnostic Procedures
Pharmaceutical Compositions

50 patents:

1. 12036316 - Oral rifamycin SV compositions (2024-07-16),
2. 12011483 - Liquid delivery composition (2024-06-18),
3. 11986484 - 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors (2024-05-21),
4. 11712443 - 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors (2023-08-01),
5. 11564883 - Oral rifamycin SV compositions (2023-01-31),
6. 11123460 - Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection (2021-09-21),
7. 10993949 - 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors (2021-05-04),
8. 10925978 - Liquid composition in the form of emulsion or microemulsion for rectal administration containing at least one dye, and its use in a diagnostic endoscopic procedure of sigmoid colon and/or rectum (2021-02-23),
9. 10849979 - Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection (2020-12-01),
10. 10660858 - Controlled release and taste masking oral pharmaceutical composition (2020-05-26),
11. 10646497 - 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors (2020-05-12),
12. 10413611 - Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection (2019-09-17),
13. 10307375 - Controlled release and taste masking oral pharmaceutical composition (2019-06-04),
14. 10265420 - Solid composition for the oral administration of dyes and diagnostic use thereof (2019-04-23),
15. 10231980 - Cortexolone 17alpha-benzoate for use in the treatment of tumours (2019-03-19),
Cosmo Technologies Limited, based in Dublin, Ireland, specializes in the development of innovative pharmaceutical compositions. The company focuses on advanced drug delivery systems, particularly in the areas of oral rifamycin formulations and liquid delivery methods. Their expertise extends to the formulation of cortexolone and tumor treatment solutions, utilizing emulsions and microemulsions for enhanced therapeutic efficacy. Cosmo Technologies is committed to improving patient outcomes through controlled release technologies and effective taste masking strategies.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

50 Patents

#39 in Dublin

#65 in Ireland

#13,996 in the World

Dublin, IE
Dublin, Ireland

Cosmo Technologies Limited

Forward Citations = 318

17 inventors:

goldMedal Roberto Villa (32 out of 33 patents)

silverMedal Mauro Ajani (31 out of 44 patents)

bronzeMedal Massimo Pedrani (22 out of 23 patents)

4.  Lorenzo Fossati (22 out of 23 patents)

5.  Luigi Moro (17 out of 32 patents)

Please report any incorrect information to [email protected]
Loading…